NEW YORK (GenomeWeb News) – The Weizmann Institute of Science has received a $50 million donation to fund operations at the new Israel National Center for Personalized Medicine (INCPM), which is located at the Weizmann campus in Rehovot, Israel.
The INCPM is focused on conducting research involving genomics, protein profiling, bioinformatics, and drug discovery to advance new personalized approaches to diagnosing, treating, and preventing diseases.
The American Committee for the Weizmann Institute of Science said today that Nancy and Stephen Grand committed the funding, and that the INCPM has incorporated the Grand name into its own.
Now named the Nancy and Stephen Grand INCPM, the center is a national consortium that serves Israel's life sciences research community, hospitals, and industry. It will engage in international collaborations and "[draw] upon Israel's diverse genetic pool comprised of populations from around the globe," the committee said.
The institute is composed of the Crown Institute for Genomics; the de Botton Institute for Protein Profiling; the Wohl Institute for Drug Discovery; and the Mantoux Bioinformatics Institute.